Is a single set of negative blood cultures sufficient to ensure clearance of bloodstream infection in patients with Staphylococcus aureus bacteremia? The skip phenomenon

被引:15
作者
Fiala, Justin [1 ]
Palraj, Bharath Raj [1 ,2 ]
Sohail, M. Rizwan [1 ,2 ,3 ,4 ]
Lahr, Brian [5 ]
Baddour, Larry M. [1 ,2 ,3 ]
机构
[1] Mayo Clin, Dept Med, Rochester, MN USA
[2] Mayo Clin, Dept Med, Div Infect Dis, Rochester, MN USA
[3] Mayo Clin, Dept Cardiovasc Dis, Rochester, MN USA
[4] Mayo Sch Grad Med Educ, Rochester, MN USA
[5] Mayo Clin, Coll Med, Biomed Stat & Informat, Rochester, MN USA
关键词
Staphylococcus aureus; Bacteremia; Blood stream infections; Skip phenomenon; Blood culture; RECURRENCE; CEFAZOLIN; ADULTS; RISK;
D O I
10.1007/s15010-019-01339-w
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background The most recent version of the Infectious Diseases Society of America guidelines for the treatment of methicillin-resistant Staphylococcus aureus infections states that a single set of negative blood cultures is sufficient to demonstrate clearance of bacteremia. However, S. aureus might exhibit fluctuating blood culture positivity, labeled as "the skip phenomenon". Our objectives were to determine the prevalence of the skip phenomenon in a cohort of hospitalized patients with S. aureus bacteremia and to determine the associated clinical variables. Methods We conducted a nested case-control study, using a previous cohort of 757 adult inpatients between July 2006 and June 2011 with >= 3 days of S. aureus bacteremia. Each case of S. aureus bacteremia with the skip phenomenon was matched to 2 to 4 controls based on age, gender, and duration of bacteremia. The association of clinical characteristics with the skip phenomenon was analyzed via conditional logistic regression. Results Of the 757 patients in the cohort, 29 (4%) had the skip phenomenon. 26 (90%) patients in the cases group were male. The median age was 69.4 years (interquartile range [IQR] 58.7 to 80.3). Although an attempt to match for the duration of bacteremia was done, there was a statistically longer duration in patients with cases as compared to that in controls (median [IQR], 10 [7-12] days, vs 8 [6-10] days; P = 0.015). Accordingly, duration of bacteremia was adjusted for in regression models. Notably, 26 (90%) patients in the case group were receiving chronic immunosuppressive therapy, as compared to 69 (79%) patients in the control group (P = 0.427). Conclusion Our findings prompt consideration of a practice chance to obtain serial negative blood cultures to ensure clearance of bacteremia among patients with S. aureus bacteremia.
引用
收藏
页码:1047 / 1053
页数:7
相关论文
共 12 条
[1]   Comparative effectiveness of cefazolin versus cloxacillin as definitive antibiotic therapy for MSSA bacteraemia: results from a large multicentre cohort study [J].
Bai, Anthony D. ;
Showler, Adrienne ;
Burry, Lisa ;
Steinberg, Marilyn ;
Ricciuto, Daniel R. ;
Fernandes, Tania ;
Chiu, Anna ;
Raybardhan, Sumit ;
Science, Michelle ;
Fernando, Eshan ;
Tomlinson, George ;
Bell, Chaim M. ;
Morris, Andrew M. .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2015, 70 (05) :1539-1546
[2]   Staphylococcus aureus bacteremia -: Recurrence and the impact of antibiotic treatment in a prospective multicenter study [J].
Chang, FY ;
Peacock, JE ;
Musher, DM ;
Triplett, P ;
MacDonald, BB ;
Mylotte, JM ;
O'Donnell, A ;
Wagener, MM ;
Yu, VL .
MEDICINE, 2003, 82 (05) :333-339
[3]   Clinical characterization of breakthrough bacteraemia: a survey of 392 episodes [J].
Dupla, ML ;
Martinez, JA ;
Vidal, F ;
Almela, M ;
Lopez, J ;
Marco, F ;
Soriano, A ;
Richart, C ;
Mensa, J .
JOURNAL OF INTERNAL MEDICINE, 2005, 258 (02) :172-180
[4]   Health care-associated bloodstream infections in adults: A reason to change the accepted definition of community-acquired infections [J].
Friedman, ND ;
Kaye, KS ;
Stout, JE ;
McGarry, SA ;
Trivette, SL ;
Briggs, JP ;
Lamm, W ;
Clark, C ;
MacFarquhar, J ;
Walton, AL ;
Reller, LB ;
Sexton, DJ .
ANNALS OF INTERNAL MEDICINE, 2002, 137 (10) :791-797
[5]   Risk factors for recurrence in patients with Staphylococcus aureus infections complicated by bacteremia [J].
Kreisel, Kristen ;
Boyd, Kristina ;
Langenberg, Patricia ;
Roghmann, Mary-Claire .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2006, 55 (03) :179-184
[6]  
Liu C, 2011, CLIN INFECT DIS, V52, P285, DOI [10.1093/cid/cir034, 10.1093/cid/ciq146]
[7]   Comparative Effectiveness of Cefazolin Versus Nafcillin or Oxacillin for Treatment of Methicillin-Susceptible Staphylococcus aureus Infections Complicated by Bacteremia: A Nationwide Cohort Study [J].
McDanel, Jennifer S. ;
Roghmann, Mary-Claire ;
Perencevich, Eli N. ;
Ohl, Michael E. ;
Goto, Michihiko ;
Livorsi, Daniel J. ;
Jones, Makoto ;
Albertson, Justin P. ;
Nair, Rajeshwari ;
O'Shea, Amy M. J. ;
Schweizer, Marin L. .
CLINICAL INFECTIOUS DISEASES, 2017, 65 (01) :100-106
[8]   Complete adherence to evidence-based quality-of-care indicators for Staphylococcus aureus bacteremia resulted in better prognosis [J].
Nagao, Miki ;
Yamamoto, Masaki ;
Matsumura, Yasufumi ;
Yokota, Isao ;
Takakura, Shunji ;
Teramukai, Satoshi ;
Ichiyama, Satoshi .
INFECTION, 2017, 45 (01) :83-91
[9]   Predicting Risk of Endocarditis Using a Clinical Tool (PREDICT): Scoring System to Guide Use of Echocardiography in the Management of Staphylococcus aureus Bacteremia [J].
Palraj, Bharath Raj ;
Baddour, Larry M. ;
Hess, Erik P. ;
Steckelberg, James M. ;
Wilson, Walter R. ;
Lahr, Brian D. ;
Sohail, M. Rizwan .
CLINICAL INFECTIOUS DISEASES, 2015, 61 (01) :18-28
[10]   Predictors of Mortality in Staphylococcus aureus Bacteremia [J].
van Hal, Sebastian J. ;
Jensen, Slade O. ;
Vaska, Vikram L. ;
Espedido, Bjoern A. ;
Paterson, David L. ;
Gosbell, Iain B. .
CLINICAL MICROBIOLOGY REVIEWS, 2012, 25 (02) :362-386